Blue Jet Healthcare Limited (BLUEJET.BO)
INR 584.1
(1.64%)
INR 584.1
(1.64%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.29 Billion INR | -2.8% |
| 2022 | 2.43 Billion INR | -11.57% |
| 2021 | 2.68 Billion INR | 26.52% |
| 2020 | 2.15 Billion INR | -3.59% |
| 2019 | 2.18 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 815.6 Million INR | 53.95% |
| 2024 Q1 | 442.63 Million INR | -14.41% |
| 2023 Q2 | 626.24 Million INR | 1.09% |
| 2023 Q3 | 613.36 Million INR | -2.06% |
| 2023 Q1 | 619.48 Million INR | -10.64% |
| 2023 Q4 | 530.66 Million INR | -13.48% |
| 2023 FY | - INR | -2.8% |
| 2022 Q2 | 587.06 Million INR | 36.59% |
| 2022 FY | - INR | -11.57% |
| 2022 Q4 | 693.25 Million INR | 19.03% |
| 2022 Q3 | 582.4 Million INR | -0.79% |
| 2022 Q1 | 429.8 Million INR | 0.0% |
| 2021 FY | - INR | 26.52% |
| 2020 FY | - INR | -3.59% |
| 2019 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 10.12 Million INR | -22542.236% |
| Biocon Limited | 41.52 Billion INR | 94.48% |
| Concord Biotech Limited | 4.65 Billion INR | 50.8% |
| Dishman Carbogen Amcis Limited | 3.07 Billion INR | 25.376% |
| FERMENTA BIOTECH LIMITED | 262.68 Million INR | -772.652% |
| GENOMIC VALLEY BIOTECH LIMITED | 147.4 Thousand INR | -1555034.937% |
| Lyka Labs Limited | 167.58 Million INR | -1267.811% |
| Panacea Biotec Limited | -200.6 Million INR | 1242.722% |
| SAMSRITA LABS LIMITED | -2.46 Million INR | 93265.884% |
| Servoteach Industries Limited | - INR | -Infinity% |
| SMS Lifesciences India Limited | 349.41 Million INR | -556.049% |
| Supriya Lifescience Limited | 1.83 Billion INR | -24.869% |
| Syngene International Limited | 10.84 Billion INR | 78.867% |
| TAKE Solutions Limited | -1.05 Billion INR | 318.14% |
| Titan Biotech Limited | 360.29 Million INR | -536.227% |
| Transgene Biotek Limited | -4.33 Million INR | 52930.145% |
| Vanta Bioscience Limited | 14.19 Million INR | -16053.196% |